On purchase of this report, you get next three (3) quarterly updates of the report for free.
The North American cerebral oximeter device market is driven by cardiac/vascular surgery, shoulder surgery, single lung ventilation, and others. The market was valued at $41.2 million in 2013 and is estimated to reach $56.5 million by 2018 at a CAGR of 6.5% from 2013 to 2018
The report, ‘North American Cerebral Oximeters Devices Market Forecast, 2012-2018’, analyzes the market in terms of applications such as cardiac/vascular surgery, shoulder surgery, and single lung ventilation. With a market value of $0.08 billion, the cerebral oximeter market has accounted for 8%-10% in terms of value towards the total brain monitoring device industry. The cerebral oximeter market has been witnessing maximum growth because of an increase in the patient pool and procedure numbers of neurological disorders. A rise in incidence of post-surgical cerebrovascular accidents has triggered the need for enhanced and automated brain monitoring devices. Therefore, these devices are being incorporated extensively in hospitals and clinics to assess the activity of sedatives and anesthesia. According to the estimates of the WHO, in 2011, the global prevalence of epilepsy and multiple sclerosis was calculated at 50 million and 2.5 million respectively.
North America is the largest market for cerebral oximeter devices, followed by Europe and Asia. The North American region offers a huge untapped market for these devices due to the rising awareness of neurological disorders, increase in purchasing power, and an increasing number of people with multiple sclerosis, epilepsy, cerebrovascular diseases, Parkinson’s, and Alzheimer’s disease.
Complete report is available @ http://www.reportsnreports.com/reports/313853-north-american-cerebral-oximeters-market-research-report.html .